![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 06, 2017 9:54:18 PM
Great volume today, another nice breather/consolidation day before we start moving into $1.50 territory, then $2 - $2.50 is next.
It's been like this since the mid 20's...
We should be at $4 based on the most recent deal...
20x ($14m x 51%) = $140 million = $3.88
25x (14m x 51%) = $178 million = $4.44
Don't forget what we have :
* Access to an extensive catalogue of over 2000 hemp and cannabis strains
Hmm I wonder what they plan to do with these IP 2000 strains ? Oh yeah..they said it in last NR:
''The Company will aim to work with large growers and provide access for them to a comprehensive catalogue of cannabis strains. ''
Work with large growers ? Hmmmm what else... Oh yes I forgot last paragraph of 1st NR:
* MJ Biopharma's expertise lies in its extracts and custom formulations. The company will also aim to in- license and joint venture on best in class technologies and products for both the medicinal and recreational markets - domestically and internationally.
What else do we have ?
* FDA-certified laboratory
* R&D facility
* Rooting station
* Weening facilities
* Low cost, high efficiency lab.
* Existing cannabis license
* An export license
Don't forget the plan:
VIN (MJ BIOPHARMA) PLAN:
* Expand rapidly into the hemp, cannabis and cannabinoid (CBD) sectors across Europe.
* Utilize our first mover advantage to take a leading market position in multiple countries
* "Given the current marketplace dynamics, existing customer base and technology we now have access to; we plan to immediately roll out several new hemp and CBD initiatives.
* "Our goal has always been to control every step of the production process from genetics, right through to extraction, ensuring only the highest quality extracts are used in the formulation of our strips, time release capsules and other products currently under development for the medical and recreational cannabis space,"
About MJ Biopharma
MJ Biopharma is a cannabis technology company with a team of highly experienced business and medical professionals, biochemists and researchers. The company is currently focused on the following areas of interest:
Manufacturing breath strips;
Time release capsules;
Extract oils;
Food products and infused juices, teas, coffee and extract drinks;
Pharmaceutical grade delivery systems;
Recent MBAIF News
- Emerging Markets Report: Meeting the Moment • InvestorsHub NewsWire • 11/21/2023 04:18:47 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM